Kidney Transplant Rejection
📧 Sign up to get email alerts when something new happens for Kidney Transplant Rejection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-12Clinical Trial Update: Belumosudil for Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation [Phase 2]
Phase 2 clinical trial update for Belumosudil to address interstitial fibrosis and tubular atrophy following kidney transplantation, in the …
-
CLINICAL_TRIALS research · 2025-10-14Clinical Trial Update: Adipose-derived MSC to Treat Rejection in Kidney Transplant Recipients [Phase 1]
A Phase 1 clinical trial evaluating adipose-derived mesenchymal stem cells to treat rejection in kidney transplant recipients is currently r…
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: To Explore the Application Value of Magnetic Resonance Imaging in Noninvasive Quantitative Evaluation of Graft Function and Systemic Metabolism After Renal Transplantation
A clinical trial update investigating the use of magnetic resonance imaging to noninvasively quantify graft function and systemic metabolism…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Dd-cfDNA and Treg in Prediction of Kidney Transplant Acute Rejection
This study is evaluating whether donor-derived cell-free DNA (Dd-cfDNA) and regulatory T cells (Treg) can predict acute kidney transplant re…
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: Molecular Transcriptomics in Diagnosing Pediatric Kidney Transplant Rejection: the PANDA-Kids-ATLAS Study
This trial investigates using molecular transcriptomics to diagnose kidney transplant rejection in children. The PANDA-Kids-ATLAS study is c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-23Clinical Trial Update: Daratumumab for Late Antibody-Mediated Rejection [NA]
A clinical trial is evaluating daratumumab for late antibody-mediated rejection in kidney transplant recipients, and the study is currently …
-
CLINICAL_TRIALS research · 2025-07-17Clinical Trial Update: Australian Genomics Of Chronic Allograft Dysfunction Study
The Australian Genomics Of Chronic Allograft Dysfunction study is currently recruiting, sponsored by Western Sydney Local Health District, f…
-
CLINICAL_TRIALS research · 2025-07-08Clinical Trial Update: CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study using CRISPR-edited HLA donor kidneys to reduce transplant rejection risk, with recru…
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: TACKLE-IT Trial - Treat Acute T Cell Rejection With Evidence and Confidence in Kidney Transplant Recipients [Phase 3]
Phase 3 TACKLE-IT trial investigates treatment for acute T cell rejection in kidney transplant recipients. The study also references a pancr…
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Microbiome and Immunosuppression: The Mission Study
The Mission Study investigates the microbiome's role in immunosuppression for kidney transplant patients and is currently ACTIVE_NOT_RECRUIT…
-
CLINICAL_TRIALS research · 2025-05-31Clinical Trial Update: Molecular Landscape of Microvascular Inflammation in Kidney Allografts
A clinical trial investigating the molecular landscape of microvascular inflammation in kidney allografts is currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: Immune Monitoring of Prevalent Kidney Transplant Recipients Using Torque Teno Virus: A Single-Center, Prospective Cohort Study
This ClinicalTrials.gov entry describes an ongoing single-center prospective cohort study evaluating immune monitoring in kidney transplant …
-
CLINICAL_TRIALS research · 2025-04-24Clinical Trial Update: Longitudinal Changes in Donor-Derived Cell-Free DNA With Tocilizumab Treatment for Chronic Antibody-Mediated Rejection
A clinical trial update investigates longitudinal changes in donor-derived cell-free DNA with tocilizumab treatment for chronic antibody-med…
-
CLINICAL_TRIALS research · 2025-04-13Clinical Trial Update: Transplant Antibody-Mediated Rejection: Guiding Effective Treatments [Phase 3]
A Phase 3 clinical trial evaluating treatments for antibody-mediated rejection in kidney transplant patients has been terminated.
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: Impact of the Microbiota on the Likelihood of Renal Graft Rejection
A clinical trial is studying how the gut microbiota affects the likelihood of kidney transplant rejection, and the study is currently recrui…
-
CLINICAL_TRIALS research · 2025-04-09Clinical Trial Update: Added Value of 18 FDG Pet-scanner in Diagnosis and Management of Subclinical Rejection in Kidney Transplant Patients [NA]
This clinical trial evaluates how FDG-PET imaging can improve diagnosis and management of subclinical rejection in kidney transplant patient…
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: Study of the Plasma and Urinary cfDNA of in Kidney Transplant Patients
This clinical trial investigates plasma and urinary cell-free DNA as biomarkers for kidney transplant rejection. The study is currently recr…
-
CLINICAL_TRIALS research · 2025-04-03Clinical Trial Update: TocIlizumab in Late/Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients [Phase 3]
Clinical trial update for a Phase 3 study of tocilizumab in late/chronic active antibody-mediated rejection after kidney transplantation. Th…
-
CLINICAL_TRIALS research · 2025-03-28Clinical Trial Update: GEnomic Medicine in Kidney Transplantation Study
A genomic medicine study for kidney transplantation is not yet recruiting. It is sponsored by Western Sydney Local Health District and targe…
-
CLINICAL_TRIALS research · 2025-03-14Clinical Trial Update: Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation [Phase 2]
A Phase 2 clinical trial update for fingolimod aimed at reducing interstitial fibrosis and tubular atrophy after kidney transplantation, wit…
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: Autologous Tolerogenic Dendritic Cells (ATDC) for Highly Sensitized Kidney Transplant Recipients [Phase 1]
Phase 1 clinical trial evaluating autologous tolerogenic dendritic cells for highly sensitized kidney transplant recipients; the study is cu…
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: PRObiotics for KIdney Transplantation [NA]
A clinical trial update shows enrollment by invitation for a study using probiotics in kidney transplant recipients to address urinary tract…
-
CLINICAL_TRIALS research · 2025-02-10Clinical Trial Update: Safety & Tolerability Study of Chimeric Antigen Receptor T-Reg Cell Therapy in Living Donor Renal Transplant Recipients [Phase 1, Phase 2]
Early-phase safety and tolerability study evaluating a chimeric antigen receptor regulatory T cell (CAR-Treg) therapy in living donor kidney…
-
CLINICAL_TRIALS research · 2024-10-31Clinical Trial Update: Observational Cohort Study Renal Transplantation University Hospitals Leuven
This entry describes an observational cohort study on renal transplantation conducted by University Hospitals Leuven; the trial is currently…
-
CLINICAL_TRIALS research · 2024-10-04Clinical Trial Update: Clinical Impact of the IBox As an Early Intervention TooL [NA]
An update on the clinical impact of the IBox early intervention tool for kidney-related conditions; the study is currently active but not re…